A Proteomic Analysis on Human Sperm Tail: Comparison Between Normozoospermia and Asthenozoospermia
Overview
Reproductive Medicine
Affiliations
Purpose: Asthenozoospermia is a common cause of human male infertility characterized by reduced sperm motility. The molecular mechanism that impairs sperm motility is not fully understood. This study proposed to identify novel biomarkers by focusing on sperm tail proteomic analysis of asthenozoospermic patients.
Methods: Sperm were isolated from normozoospermic and asthenozoospermic semen samples. Tail fractions were obtained by sonication followed by Percoll gradient. The proteins were extracted by solubilization and subjected to two-dimensional gel electrophoresis (2-DE); then, the spots were analyzed using Image Master 2D Platinum software. The significantly increased/decreased amounts of proteins in the two groups were exploited by matrix-assisted laser desorption-ionization time-of-flight/time-of-flight (MALDI-TOF-TOF) mass spectrometry.
Results: Three hundred ninety protein spots were detected in both groups. Twenty-one protein spots that had significantly altered amounts (p < 0.05) were excised and exploited using MALDI-TOF-TOF mass spectrometry. They led to the identification of the following 14 unique proteins: Tubulin beta 2B; glutathione S-transferase Mu 3; keratin, type II cytoskeletal 1; outer dense fiber protein 2; voltage-dependent anion-selective channel protein 2; A-kinase anchor protein 4; cytochrome c oxidase subunit 6B; sperm protein associated with the nucleus on the X chromosome B; phospholipid hydroperoxide glutathione peroxidase-mitochondrial; isoaspartyl peptidase/L-asparaginase; heat shock-related 70 kDa protein 2; stress-70 protein, mitochondrial; glyceraldehyde-3-phosphate dehydrogenase, testis-specific and clusterin.
Conclusion: Fourteen proteins present in different amounts in asthenozoospermic sperm tail samples were identified, four of which are reported here for the first time. These proteins might be used as markers for the better diagnosis of sperm dysfunctions, targets for male contraceptive development, and to predict embryo quality.
Willathgamuwa N, Nammunige M, Thennakoon T, Nissanka N, Withanage Dona M, Rodrigo N BMJ Open. 2024; 14(12):e089058.
PMID: 39740947 PMC: 11749122. DOI: 10.1136/bmjopen-2024-089058.
Omics experiments in Iran, a review in endocrine and metabolism disorders studies.
Hosseinkhani S, Arjmand B, Bandarian F, Aazami H, Hadizadeh N, Najjar N J Diabetes Metab Disord. 2024; 23(2):1539-1544.
PMID: 39610495 PMC: 11599483. DOI: 10.1007/s40200-021-00727-0.
Sulc A, Czetany P, Mate G, Ballo A, Semjen D, Szanto A Int J Mol Sci. 2024; 25(15).
PMID: 39125928 PMC: 11313448. DOI: 10.3390/ijms25158358.
Proteomic analysis of fipronil-induced molecular defects in spermatozoa.
Bae J, Kwon W Sci Rep. 2024; 14(1):7668.
PMID: 38561386 PMC: 10985004. DOI: 10.1038/s41598-024-57876-4.
Bringing proteomics to bear on male fertility: key lessons.
Parkes R, X Garcia T Expert Rev Proteomics. 2024; 21(4):181-203.
PMID: 38536015 PMC: 11426281. DOI: 10.1080/14789450.2024.2327553.